Completed PHASE4 INTERVENTIONAL 2-arm NCT02244086

Analgesic Efficacy of Two Concentrations of Bupivacaine in Women in Labor (EBWL)

Analgesic Efficacy of Two Concentrations of Bupivacaine in Women in Labor.

Sponsor: Coordinación de Investigación en Salud, Mexico

Interventions bupivacaine

Updated 5 times since 2017 Last updated: May 25, 2016 Started: Jun 30, 2013 Primary completion: Oct 31, 2013 Completion: Oct 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02244086, this PHASE4 trial focuses on Obstetric Pain and remains completed. Sponsored by Coordinación de Investigación en Salud, Mexico, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jun 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Coordinación de Investigación en Salud, Mexico
Instituto Mexicano del Seguro Social

Data source: Coordinación de Investigación en Salud, Mexico

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cancún, Mexico